Reporting owner · CIK 0002091798

Inglis Tiffany Eul Davis

SEC Form 4 history across 1 companies, 2 transactions and 2 filings.

CMOChief Medical OfficerSERA PROGNOSTICS, INC.
Open-market transaction mix0% buys0 buys · 2 sales

Available history · Sep 10, 2026 – Oct 12, 2026

Filings2Form 4 records
Buying$00 purchases
Selling$17.3K2 sales
Net value−$17.3KBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Inglis Tiffany Eul Davis transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
SERASERA PROGNOSTICS, INC.
Inglis Tiffany Eul DavisCMOS · saleSEC filing ↗-$16.2kView disclosure →
SERASERA PROGNOSTICS, INC.
Inglis Tiffany Eul DavisCMOS · saleSEC filing ↗-$972View disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

sale at SERA PROGNOSTICS, INC. on Oct 12, 2026 valued at $16,289.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at SERA PROGNOSTICS, INC. on Oct 12, 2026 valued at $16,289.

Review SEC filing

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Sep 202601$0.00$972.00-$972.00
Oct 202601$0.00$16,288.72-$16,288.72

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$8.6K
Median P/S size$8.6K
Direct2
Indirect0
Oct 12, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Associated companies

Companies in the disclosed reporting history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in available history

A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

2 observations · Sep 10, 2026 – Oct 12, 2026. Window ends at the latest available report, not today.

Selected observation · Oct 12, 202683,565 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 10, 202691,589Sep 11, 2026View transaction
Oct 12, 202683,565Oct 13, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Inglis Tiffany Eul Davis Insider Activity FAQ

SEC Form 4 context

Who is Inglis Tiffany Eul Davis?

Inglis Tiffany Eul Davis is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002091798.

Which companies has Inglis Tiffany Eul Davis reported transactions for?

SERA PROGNOSTICS, INC.

When was Inglis Tiffany Eul Davis's latest insider buy?

No open-market insider purchase is available for this period.

When was Inglis Tiffany Eul Davis's latest insider sale?

sale at SERA PROGNOSTICS, INC. on Oct 12, 2026 valued at $16,289.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.